News for Aridis Pharmaceuticals Stock (ARDS)

Aridis Pharmaceuticals to Host Fireside Chat with Analysts to Discuss 2021 Outlook for its Lead Programs and Novel mAb Discovery Platform on December 4th, 2020

PRNewsWire • 11/24/20

Aridis Pharmaceuticals Announces Third Quarter 2020 Results

PRNewsWire • 11/20/20

Aridis Pharmaceuticals to Present at the ROTH Capital Partners 2020 MedTech Innovation Forum on a COVID-19 Panel

PRNewsWire • 10/27/20

Aridis Pharmaceuticals Reports Positive Preclinical Efficacy Data of a Highly Effective Inhaled Treatment Supporting a Proposed Self-Administered Therapy for COVID-19 Patients

PRNewsWire • 10/19/20

Aridis Pharmaceuticals Announces $8.5 Million Registered Direct Offering

PRNewsWire • 10/14/20

Aridis Announces Agreement with the FDA on Updated Phase 2 Clinical Trial Design for AR-501

PRNewsWire • 09/08/20

Aridis Pharmaceuticals to Present at Upcoming Investor Conferences

PRNewsWire • 09/04/20

Aridis Pharmaceuticals Announces Second Quarter 2020 Results

PRNewsWire • 08/11/20

Aridis Pharmaceuticals to Participate in Cantor Fitzgerald Virtual Symposium: Winning Ways to Treat Infections and COVID-19

PRNewsWire • 06/26/20

8 Stock Catalysts For The Week Ahead (June 22)

Benzinga • 06/22/20

Aridis Reports AR-501 Clinical Data: Positive Safety Data in Healthy Subjects of a Phase 1/2a Clinical Trial

PRNewsWire • 06/22/20

Aridis Pharmaceuticals Appoints Dr. Hasan Jafri as Chief Medical Officer

PRNewsWire • 06/15/20

Will Aridis Pharmaceuticals Continue to Surge Higher?

Zacks Investment Research • 05/07/20

Aridis Shares Plummet After Pneumonia Drug Flunks Midstage Study

Benzinga • 09/03/19

Aridis Pharmaceuticals stock plunges after drug trial fails to meet primary endpoint

Market Watch • 09/03/19

Aridis Pharmaceuticals Upgraded to Buy: Here's Why

Zacks Investment Research • 04/02/19